Related Experiment Video
Updated: Jul 14, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease
P W Connelly1, G F Maguire, J A Little
1Lipid Research Clinic, St. Michael's Hospital, Toronto, Canada.
Abstract:
A 60-yr-old woman and her brother, products of a consanquinous mating, were chylomicronemic. The chylomicronemia in both subjects was found to be due to the absence of functional apoCII. A mutant form, designated apoCIISt. Michael (apoCIIs), was identified by two-dimensional electrophoresis and Western blot using anti-apoCII antiserum. The isoelectric point of apoCIIs was similar to that of normal apoCII, but its apparent molecular weight was 3,000 greater. Tryptic peptides of apoCIIs were identified that had retention times in reverse-phase high pressure liquid chromatography and amino acid compositions indistinguishable from that of residues 1 to 48 and 51 to 55 of normal apoCII. The complete sequence of apoCIIs was deduced from a combination of the sequence analysis of tryptic peptides corresponding to residues 56 through 96 and the known sequence of the apoCII gene. ApoCIIs differed from apoCII at residue 70 where Gln70 was replaced by Pro70 and the sequence terminated with Pro96. This is consistent with a base insertion in the codon for Asp69 or Gln70 in the apoCII gene and a subsequent translation reading frame shift. Both patients were homozygous for apoE-4. This and the absence of normal apoCII is consistent with homozygozity at the apoE-CII gene locus on chromosome 19. Both siblings and several relatives had premature ischemic vascular disease, in contrast with its apparent absence in other apoCII-deficient families.
Insights
A rare genetic mutation caused a lack of functional apolipoprotein CII (apoCII) in siblings, leading to severe hypertriglyceridemia (chylomicronemia). This apoCII variant, apoCII St. Michael, resulted from a gene defect and was linked to premature vascular disease.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Chylomicronemia is a severe lipid disorder characterized by elevated triglyceride-rich lipoproteins.
- Apolipoprotein CII (apoCII) is crucial for chylomicron metabolism and triglyceride clearance.
Purpose of the Study:
- To investigate the molecular basis of chylomicronemia in siblings from a consanguineous mating.
- To identify and characterize the genetic defect responsible for the absence of functional apoCII.
Main Methods:
- Two-dimensional electrophoresis and Western blot analysis using anti-apoCII antiserum.
- Peptide mapping via reverse-phase high-pressure liquid chromatography and amino acid composition analysis.
- Gene sequencing and deduced protein sequence analysis.
Main Results:
- A novel mutant apoCII, designated apoCII St. Michael (apoCIIs), was identified with an increased molecular weight.
- apoCIIs resulted from a frameshift mutation at Gln70, leading to premature termination at Pro96.
- Both affected siblings were homozygous for apoE-4, suggesting linkage disequilibrium at the apoE-CII gene locus on chromosome 19.
Conclusions:
- The identified apoCII mutation is causative of chylomicronemia.
- The apoCII deficiency, in conjunction with apoE-4 homozygosity, may predispose to premature ischemic vascular disease.
- This case highlights the importance of apoCII in lipid metabolism and cardiovascular health.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
RNA Editing
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Peripheral Artery Disease I: Introduction
Cytomegalovirus Disease